Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for metabolic and endocrine disorders. Its clinical programs include VK2735 and VK2809, targeting conditions such as obesity, non-alcoholic steatohepatitis (NASH), and lipid disorders.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.